Persistent Body Fat Mass and Inflammatory Marker Increases after Long-Term Cure of Cushing’s Syndrome-Reference-Cited by-同舟云学术

Persistent Body Fat Mass and Inflammatory Marker Increases after Long-Term Cure of Cushing’s Syndrome

Published:2009-09-01 Issue:9 Volume:94 Page:3365-3371
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Barahona María-José¹,Sucunza Nuria¹,Resmini Eugenia¹,Fernández-Real José-Manuel²,Ricart Wifredo²,Moreno-Navarrete José-María²,Puig Teresa³,Farrerons Jordi⁴,Webb Susan M.¹

Affiliation:

1. Endocrinology and Medicine Departments and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), Instituto de Salud Carlos III, Barcelona, and Hospital Sant Pau (M.-J.B., N.S., E.R., S.M.W.), Universitat Autònoma de Barcelona, 08025 Barcelona, Spain

2. Endocrinology Department (J.-M.F.-R., W.R., J.-M.M.-N.), Institut d′Investigació Biomèdica de Girona and CIBER Fisiopatologia de la Obesidad y Nutrición CB06/03/010, Hospital Josep Trueta, 17007 Girona, Spain

3. Departments of Epidemiology (T.P.), Hospital Sant Pau, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain

4. Internal Medicine (J.F.), Hospital Sant Pau, Universitat Autònoma de Barcelona, 08025 Barcelona, Spain

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/94/9/3365/9066179/jcem3365.pdf

Reference31 articles.

1. Characterization of the metabolic phenotypes of Cushing’s syndrome and growth hormone deficiency: a study of body composition and energy metabolism.;Burt;Clin Endocrinol (Oxf),2006

2. Osteoporosis associated with excess glucocorticoids;Shaker;Endocrinol Metab Clin North Am,2005

3. Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing’s syndrome: a longitudinal study.;Ueland;J Clin Endocrinol Metab,2003

4. Loss of body cell mass in Cushing’s syndrome: effect of treatment.;Pirlich;J Clin Endocrinol Metab,2002

5. Persistence of increased cardiovascular risk in patients with Cushing’s disease after five years of successful cure.;Colao;J Clin Endocrinol Metab,1999

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sleep disruption in patients with active and treated endogenous Cushing’s syndrome;Pituitary;2024-09-09

2. An Overview of Cardiovascular Risk in Pituitary Disorders;Medicina;2024-07-30

3. Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing’s syndrome: a pilot study;Frontiers in Endocrinology;2024-07-17

4. Current Challenges and Future Directions in the Assessment of Glucocorticoid Status;Endocrine Reviews;2024-05-25

5. Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?;Biochemical Pharmacology;2024-05